Egis And mAbxience Ally On Multiple Biosimilars In CEE

Agreement For Two Candidates Could Expand To Cover More Markets

 
• By Dave Wallace
  
The deal gives mAbxience access to CEE markets (Shutterstock)

More from Deals

More from Products